Pacific Biosciences Earnings Estimate

PACB Stock  USD 1.84  0.03  1.66%   
By analyzing Pacific Biosciences' earnings estimates, investors can diagnose different trends across Pacific Biosciences' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Pacific Biosciences of is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Pacific Biosciences is projected to generate -0.125875 in earnings per share on the 31st of December 2026. Pacific Biosciences earnings estimates show analyst consensus about projected Pacific Biosciences of EPS (Earning Per Share). It derives the highest and the lowest estimates based on Pacific Biosciences' historical volatility. Many public companies, such as Pacific Biosciences, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Pacific Biosciences' earnings estimates, investors can diagnose different trends across Pacific Biosciences' analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit Margin is expected to grow to 0.28, whereas Gross Profit is forecasted to decline to about 28.8 M. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

Pacific Biosciences Earnings per Share Projection vs Actual

About Pacific Biosciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pacific Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Pacific Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Pacific Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-1.9 B-1.8 B
Retained Earnings Total Equity-1.1 B-1.2 B
Earnings Yield(0.56)(0.58)
Price Earnings Ratio(1.46)(1.39)
Price Earnings To Growth Ratio 0.22  0.23 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. Anticipated expansion of Pacific directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pacific Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(2.10)
Revenue Per Share
0.524
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.32)
Return On Equity
(2.06)
Understanding Pacific Biosciences requires distinguishing between market price and book value, where the latter reflects Pacific's accounting equity. The concept of intrinsic value - what Pacific Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Pacific Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Pacific Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pacific Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pacific Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.